Gabanyuro Capsule 50 mg (Pregabalin)

Adult dose

This drug is administered orally in two divided doses daily without regard to meals. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Initial dose is 150 mg per day, which may be increased to 300 mg per day within 3 to 7 days, and if necessary, further increased to a maximum of 600 mg per day at 7-day intervals. - Central Neuropathic Pain: Initial dose is 150 mg per day followed by an increase to 300 mg per day after one week.

Child dose

Safety and efficacy data are insufficient for pediatric patients under 12 years of age and adolescents aged 12 to 17, therefore administration is not recommended.

This drug may increase the risk of suicidal thoughts or behaviors, therefore it is essential to closely monitor for depression or mood changes during treatment. This drug should not be used by individuals with allergies to the ingredients or by patients with certain genetic lactose intolerance. Diabetic patients should be cautious as weight gain may require adjustments in blood sugar control medication doses. If severe allergic reactions such as angioedema occur, discontinue use immediately. Elderly patients should be cautious as this medication may increase the risk of falls or injuries due to dizziness or drowsiness. Some patients may experience blurred vision or changes in sight, and should consult a physician if such symptoms occur. Discontinuing this drug abruptly may lead to withdrawal symptoms such as insomnia, headache, nausea, anxiety, so dosage should be gradually reduced as directed by a physician. Patients with a history of drug abuse or mental illness may have a risk of misuse or dependence on this medication and should take it carefully. Patients with impaired kidney function may need dosage adjustments. Patients with heart disease should take caution when using this medication. Co-administration with other centrally acting CNS depressants may increase the risk of drowsiness or respiratory depression, hence caution is advised. During the early stages of pregnancy, there may be a risk of fetal malformation; therefore, women who are pregnant or planning to become pregnant should consult a physician before use and employ effective contraception. Nursing women should discuss with their doctor whether to discontinue breastfeeding or the medication, as this drug may be transmitted through breast milk. Before driving or operating hazardous machinery, confirm if the medication causes dizziness or drowsiness, and avoid such activities if symptoms are present. In cases of overdose, symptoms such as confusion, drowsiness, depression, or seizures may arise, necessitating immediate medical attention and possible hemodialysis treatment. This medication should be kept out of the reach of children and should not be transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral or ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory irregularities accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urinary issues.

Mild side effects

Dizziness, drowsiness, confusion, impaired coordination, irritability, depression, euphoria, decreased libido, insomnia, depersonalization, sexual dysfunction, restlessness, anxiety, mood swings, emotional lability, difficulties in finding appropriate words, hallucinations, abnormal dreams, increased libido, panic attacks, impulsivity, apathy, ataxia, impaired motor coordination, balance disorders, amnesia, attention deficits, memory issues, tremors, speech disturbances, sensory disturbances, decreased sensation.

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. A cool place with a temperature between 15 to 30 degrees Celsius is suitable for storage.

Appearance

A hard capsule with a navy blue upper part and a white lower part containing white or pale yellow powder.

Package unit

30 capsules/bottle, 100 capsules/bottle